Tauriga Sciences, Inc. (TAUG)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0000 - Volume
6,334 - Avg. Volume
0 - Market Cap (intraday)
299 - Beta (5Y Monthly) -0.78
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Tauriga Sciences, Inc. produces and sells cannabidiol infused chewing gum under the Tauri-Gum brand name. It also develops anti-nausea products; and skin care products include CBD facemasks; CBD daily moisturizer; CBD anti-wrinkle dream, hand, and foot cream with hemp seed oil; CBD massage and body oil; CBD body revive roll-on; CBD transdermal patch; and CBD body spray. In addition, the company offers rainbow deluxe sampler pack, CBD non-GMO dietary supplements, and CBD scented bath bombs. It sells its products through e-commerce, distributors, and wholesale channels. The company has a collaboration agreement with Aegea Biotechnologies, Inc. to develop a rapid, multiplexed COVID-19 (novel coronavirus) test. Tauriga Sciences, Inc. was founded in 2001 and is headquartered in Wappingers Falls, New York.
www.tauriga.com--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Related News
Performance Overview: TAUG
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TAUG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TAUG
Valuation Measures
Market Cap
3.00k
Enterprise Value
492.43k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.01
Price/Book (mrq)
--
Enterprise Value/Revenue
1.57
Enterprise Value/EBITDA
-0.10
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-172.32%
Return on Equity (ttm)
-6,319.22%
Revenue (ttm)
313.5k
Net Income Avi to Common (ttm)
-6.13M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
1.02M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.76M
Research Analysis: TAUG
Company Insights: TAUG
TAUG does not have Company Insights